These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Regulation of cholesterol synthesis in the rat liver under the influence of serum cholesterol-decreasing drugs]. Kaiser W; Zöllner N Verh Dtsch Ges Inn Med; 1972; 78():1307-10. PubMed ID: 4665529 [No Abstract] [Full Text] [Related]
4. Hypolipidemic activity of some derivatives of 6H-dibenzo[b,d]pyran. Banzatti C; Branzoli U; Lovisolo PP; Melloni P; Orsini G; Salvadori P Arzneimittelforschung; 1984; 34(8):864-9. PubMed ID: 6541922 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and hypolipidemic evaluation of beta-alkylaminopropiophenone and beta-alkylaminopropio-2'-naphthone derivatives in rodents. Huang Y; Hall IH Pharmazie; 1996 Apr; 51(4):199-206. PubMed ID: 8628737 [TBL] [Abstract][Full Text] [Related]
7. [Enzyme-inducing activities of hypolipidemic agents and ultrastructural changes of the liver elicited by clofibrate (author's transl)]. Araki Y; Amagase H Fukuoka Igaku Zasshi; 1974 Jul; 65(7):465-72. PubMed ID: 4474120 [No Abstract] [Full Text] [Related]
8. Hypolipidemic-hypocholesterolemic activity of JA-20, a new polyene macrolide. Naik SR; Raman PH; Jalit RN; Karnick AK Hindustan Antibiot Bull; 1981; 23():12-7. PubMed ID: 7309549 [No Abstract] [Full Text] [Related]
9. Comparison of clofibrate and ethyl-5-(p-chlorophenoxy)-3-hydroxy-3-methylpentanoate induced changes in serum lipoprotein cholesterol and hepatic peroxisome proliferation in the normal rat. Stevens TJ; Stafford WW; Day CE; Block EM Artery; 1983; 12(2):81-94. PubMed ID: 6678582 [TBL] [Abstract][Full Text] [Related]
10. Aminophenyl ether compound (YM-95831), a new hypolipidemic agent with a high density lipoprotein elevating activity in rats. Ohata I; Sakamoto N; Nitatori R; Maeno H Arzneimittelforschung; 1983; 33(2):237-41. PubMed ID: 6682662 [TBL] [Abstract][Full Text] [Related]
11. [Cholesterol and statins]. Ferrari M G Ital Cardiol; 1997 May; 27(5):499-500. PubMed ID: 9244757 [No Abstract] [Full Text] [Related]
12. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat. Staels B; Van Tol A; Fruchart JC; Auwerx J Isr J Med Sci; 1996 Jun; 32(6):490-8. PubMed ID: 8682657 [TBL] [Abstract][Full Text] [Related]
13. Role of hypolipidemic drug clofibrate in altering iron regulatory proteins IRP1 and IRP2 activities and hepatic iron metabolism in rats fed a low-iron diet. Huang HL; Shaw NS Toxicol Appl Pharmacol; 2002 Apr; 180(2):118-28. PubMed ID: 11969379 [TBL] [Abstract][Full Text] [Related]
14. [Hypolipidemic activity of glycine and its derivatives]. Ryzhenkov VE; Molokovskiĭ DS; Ioffe DV Vopr Med Khim; 1984; 30(2):78-80. PubMed ID: 6740998 [TBL] [Abstract][Full Text] [Related]
15. [Comparative biochemical and ultrastructural study of the hepatic response induced in the rat by 2 hypolipemic agents: clofibrate and itanoxone]. Gendre PM; Marcelon G; Delhon A; Lauressergues H; Fauran F J Pharmacol; 1984; 15(2):209-22. PubMed ID: 6738078 [TBL] [Abstract][Full Text] [Related]
17. A study on the antihypercholesterolemic and antihyperlipidemic effects of cabbage extracts and their phytochemical evaluation. Jahodár L; Opletal L; Lukes J; Zdánský P; Solichová D Pharmazie; 1995 Dec; 50(12):833-4. PubMed ID: 8584567 [No Abstract] [Full Text] [Related]
18. Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats. Kim SJ; Bok SH; Lee S; Kim HJ; Lee MK; Park YB; Choi MS Toxicol Appl Pharmacol; 2005 Oct; 208(1):29-36. PubMed ID: 16164959 [TBL] [Abstract][Full Text] [Related]
19. [Pharmacology of probucol. I]. Donatelli L Clin Ter; 1984 Mar; 108(5):367-88. PubMed ID: 6232074 [No Abstract] [Full Text] [Related]
20. SCAP ligands are potent new lipid-lowering drugs. Grand-Perret T; Bouillot A; Perrot A; Commans S; Walker M; Issandou M Nat Med; 2001 Dec; 7(12):1332-8. PubMed ID: 11726974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]